Compare BSRR & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSRR | MDXG |
|---|---|---|
| Founded | 1977 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 479.7M | 530.2M |
| IPO Year | 2001 | 2007 |
| Metric | BSRR | MDXG |
|---|---|---|
| Price | $40.66 | $3.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $37.00 | $9.00 |
| AVG Volume (30 Days) | 50.4K | ★ 1.2M |
| Earning Date | 04-27-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.93% | N/A |
| EPS Growth | 10.28 | ★ 14.29 |
| EPS | ★ 0.96 | N/A |
| Revenue | N/A | ★ $418,630,000.00 |
| Revenue This Year | $11.74 | N/A |
| Revenue Next Year | $3.63 | $13.02 |
| P/E Ratio | $42.24 | ★ N/A |
| Revenue Growth | N/A | ★ 19.99 |
| 52 Week Low | $26.49 | $3.03 |
| 52 Week High | $41.22 | $7.99 |
| Indicator | BSRR | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 63.41 | 58.66 |
| Support Level | $32.33 | $3.77 |
| Resistance Level | $41.22 | $3.84 |
| Average True Range (ATR) | 1.69 | 0.13 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 86.74 | 80.00 |
Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. it offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.